Page 222 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer

Appendix Table C1.2. Trends in prostate cancer incidence rates (per 100,000 unless otherwise stated) (continued)
Author Database Groups 1980-84 1985-89 1990-94 1995-99 2000-04 2005- Statistical Notes
Year 10 analysis
PMID
21
Farkas SEER White Peak, NR
1998 +0.56
9730458 (1991)
Start of
decline,
Black −0.20
(1993)
[Rate of increase
in moderately Peak,
differentiated +0.47
disease incidence (1991)
per 100,000 Start of
persons] decline,
−0.15
(1994)

42
Shao SEER 2-4 56.2 (0.7) 24.9 (0.5) 2.3 -53.9
2009 5-7 88.8 (0.9) 167.3 (1.2) (0.1) (P<0.001)
19713548 8-10 47.5 (0.7) 50.7 (0.7) 193.3 104.5
Per 100,000 (SD), (1988-89) (1996-97) (1.2) (P<0.001)
age-adjusted to 38.3 -9.2
the 2000 US (0.5) (P<0.001)
standard (2004-
population in 5-yr 05) [absolute
age increments change
beginning at 25 between
yr. 1988-1989
and 2004-05
(p-values
from ANOVA
with linear
contrast)]
52
Schwartz SEER- Well diff. 28.2 NR 12.2 NR Additional
1999 Detroit Moderately diff. 22.8 122.9 ~100 information
10197854 Poorly diff. NR NR NR is provided
Age-adjusted (1982) (1993) (1996) in Figure 2
incidence rate of the paper

C-29